KIF5A Protein Levels in CSF May Act as Biomarker of Progressive MS

KIF5A Protein Levels in CSF May Act as Biomarker of Progressive MS

286071

KIF5A Protein Levels in CSF May Act as Biomarker of Progressive MS

The levels of KIF5A protein are elevated in the cerebrospinal fluid (CSF) — the liquid surrounding the brain and spinal cord — of people with progressive multiple sclerosis (MS) and, further, are correlated with disease progression measures in patients with relapsing-remitting MS (RRMS), a new study shows. These findings suggest that KIF5A may be used as a CSF biomarker of progressive forms of MS, but larger studies are needed to confirm this, the researchers noted.…

You must be logged in to read/download the full post.